Moleculin Biotech Statistics
Total Valuation
MBRX has a market cap or net worth of $9.97 million. The enterprise value is -$6.40 million.
| Market Cap | 9.97M |
| Enterprise Value | -6.40M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MBRX has 2.31 million shares outstanding. The number of shares has increased by 28.67% in one year.
| Shares Outstanding | 2.31M |
| Shares Change (YoY) | +28.67% |
| Shares Change (QoQ) | +22.18% |
| Owned by Insiders (%) | 5.13% |
| Owned by Institutions (%) | 11.18% |
| Float | 2.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.46 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.51 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.20% and return on invested capital (ROIC) is -126.85%.
| Return on Equity (ROE) | -87.20% |
| Return on Assets (ROA) | -68.90% |
| Return on Capital (ROIC) | -126.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.49M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.62% in the last 52 weeks. The beta is 1.84, so MBRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -56.62% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 6.91 |
| Relative Strength Index (RSI) | 56.12 |
| Average Volume (20 Days) | 14,830 |
Short Selling Information
The latest short interest is 29,954, so 1.30% of the outstanding shares have been sold short.
| Short Interest | 29,954 |
| Short Previous Month | 22,894 |
| Short % of Shares Out | 1.30% |
| Short % of Float | 1.44% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.95M |
| Pretax Income | -26.82M |
| Net Income | -26.82M |
| EBITDA | -26.70M |
| EBIT | -26.82M |
| Earnings Per Share (EPS) | -$13.04 |
Balance Sheet
The company has $16.82 million in cash and $450,000 in debt, giving a net cash position of $16.37 million or $7.08 per share.
| Cash & Cash Equivalents | 16.82M |
| Total Debt | 450,000 |
| Net Cash | 16.37M |
| Net Cash Per Share | $7.08 |
| Equity (Book Value) | 21.59M |
| Book Value Per Share | 9.34 |
| Working Capital | 13.55M |
Cash Flow
In the last 12 months, operating cash flow was -$24.80 million and capital expenditures -$124,000, giving a free cash flow of -$24.93 million.
| Operating Cash Flow | -24.80M |
| Capital Expenditures | -124,000 |
| Free Cash Flow | -24.93M |
| FCF Per Share | -$10.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.67% |
| Shareholder Yield | -28.67% |
| Earnings Yield | -268.93% |
| FCF Yield | -249.89% |
Analyst Forecast
The average price target for MBRX is $35.00, which is 711.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 711.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 22, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |